Two Sigma Investments’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-6,692
| Closed | -$74.2K | – | 3489 |
|
2024
Q3 | $74.2K | Sell |
6,692
-368
| -5% | -$4.08K | ﹤0.01% | 2862 |
|
2024
Q2 | $65.6K | Sell |
7,060
-662
| -9% | -$6.15K | ﹤0.01% | 2783 |
|
2024
Q1 | $253K | Sell |
7,722
-813
| -10% | -$26.6K | ﹤0.01% | 2556 |
|
2023
Q4 | $228K | Buy |
8,535
+6,597
| +340% | +$176K | ﹤0.01% | 2702 |
|
2023
Q3 | $117K | Sell |
1,938
-4,714
| -71% | -$285K | ﹤0.01% | 2650 |
|
2023
Q2 | $678K | Buy |
6,652
+2,104
| +46% | +$214K | ﹤0.01% | 2106 |
|
2023
Q1 | $804K | Buy |
+4,548
| New | +$804K | ﹤0.01% | 1919 |
|
2022
Q3 | – | Sell |
-3,779
| Closed | -$1.24M | – | 2839 |
|
2022
Q2 | $1.24M | Buy |
3,779
+111
| +3% | +$36.5K | ﹤0.01% | 1397 |
|
2022
Q1 | $1.6M | Buy |
3,668
+1,260
| +52% | +$551K | ﹤0.01% | 1427 |
|
2021
Q4 | $1.06M | Sell |
2,408
-1,766
| -42% | -$774K | ﹤0.01% | 1636 |
|
2021
Q3 | $2.32M | Buy |
4,174
+2,250
| +117% | +$1.25M | 0.01% | 1282 |
|
2021
Q2 | $988K | Sell |
1,924
-10,567
| -85% | -$5.43M | ﹤0.01% | 1685 |
|
2021
Q1 | $9.76M | Buy |
12,491
+5,142
| +70% | +$4.02M | 0.03% | 585 |
|
2020
Q4 | $4M | Sell |
7,349
-2,421
| -25% | -$1.32M | 0.01% | 814 |
|
2020
Q3 | $4.48M | Buy |
9,770
+3,233
| +49% | +$1.48M | 0.02% | 645 |
|
2020
Q2 | $4.02M | Buy |
6,537
+4,803
| +277% | +$2.96M | 0.02% | 620 |
|
2020
Q1 | $825K | Sell |
1,734
-1,170
| -40% | -$557K | 0.01% | 1037 |
|
2019
Q4 | $1.68M | Buy |
+2,904
| New | +$1.68M | 0.01% | 1181 |
|
2019
Q1 | – | Sell |
-3,371
| Closed | -$1.58M | – | 2505 |
|
2018
Q4 | $1.58M | Buy |
+3,371
| New | +$1.58M | 0.01% | 1134 |
|
2016
Q2 | – | Sell |
-839
| Closed | -$188K | – | 2384 |
|
2016
Q1 | $188K | Sell |
839
-274
| -25% | -$61.4K | ﹤0.01% | 1925 |
|
2015
Q4 | $675K | Buy |
+1,113
| New | +$675K | ﹤0.01% | 1410 |
|